Author Question: The nurse is caring for a patient receiving IV acyclovir. To prevent nephrotoxicity associated with ... (Read 66 times)

saliriagwu · **on:** Jul 23, 2018

The nurse is caring for a patient receiving IV acyclovir. To prevent nephrotoxicity associated with intravenous acyclovir, the nurse would do which of the following?

a. Provide a low-protein diet for 1 day before and 2 days after the acyclovir infu-sion.
b. Infuse IV fluids during and for 2 hours after the acyclovir infusion.
c. Increase the patient's intake of vitamin C rich foods.
d. Monitor urinary output every 30 minutes.

Question 2

A nurse working in a private pediatric practice is caring for a patient who has been receiving 17alpha-alkylated androgen (Fluoxymesterone).

Which clinical manifestation would cause the nurse to be concerned, and what intervention would the nurse anticipate? a. Gynecomastia; discontinuation of the drug
b. Yellowish tint to the skin and sclera; discontinuation of the drug
c. Decrease in high-density lipoprotein (HDL); titration of the medication
d. Erratic blood glucose levels; adjustment of the dose

amy.lauersdorf90 · **Reply #1 on:** Jul 23, 2018

Answer to Question 1

B
The nurse should include the infusion of IV fluids during and for 2 hours after the acyclovir in-fusion to prevent nephrotoxicity by perfusing the kidneys.
A low-protein diet is not indicted after an acyclovir infusion.
Increasing vitamin C would not help prevent nephrotoxicity.
Monitoring urine output is important but would not help prevent nephrotoxicity.

Answer to Question 2

B
A yellowish tint to the skin and sclera would most concern the nurse, because 17alpha-alkylated androgen (Fluoxymesterone) is known to cause hepatotoxicity.
Gynecomastia is expected in males.
A decrease in HDL would require monitoring of those levels but not titration of the medication.
Fluoxymesterone is not associated with erratic blood glucose levels.